Skip to content
Open access

Urolithin A Exerts Neuroprotective Effects Against Ischemic Stroke by Inhibiting Oxidative Stress and Neuroinflammation

Aug 2026 · CNS Neuroscience & Therapeutics · Vol 32 · 0 citations · 54 references
Medicine

Abstract

Ischemic stroke (IS), the main stroke type, causes neuronal injury via hypoperfusion and hypoxia, imposes heavy health burdens, and is characterized by neurological deficits driven by oxidative stress and inflammation.

Read PDF

Similar papers

Open access Aug 2026

Cholesterol Drives IFITM3 + Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke

Dysregulated microglial cholesterol metabolism has been implicated in post‐stroke neuroinflammation, yet the specific pathogenic microglial subpopulations, their molecular signatures, and the downstream inflammatory cascades remain poorly defined.

Yue-lei Cheng, Yuxi Zhou, Yong-Hui Chen et al. · 1 citation
Editorial Open access Aug 2026

Editorial for the Special Issue “Molecular Mechanisms and Treatment of Ischemia–Reperfusion Injury”

Ischemia-reperfusion injury (IRI) remains one of the most challenging obstacles in modern medicine, influencing outcomes across cardiovascular disease, organ transplantation, stroke, peripheral ischemia, and acute surgical conditions [...].

Jun Kobayashi · 0 citations
Open access Aug 2026

Scutellarin Alleviates Neuronal Apoptosis After Ischemia and Hypoxia via the HIF‐1α–CX3CR1 Axis

This study investigates the direct neuroprotective effects of scutellarin after ischemia–hypoxia, clarifies the relationship between upregulated CX3CR1 expression and neuronal apoptosis, and elucidates the mechanism by which scutellarin regulates apoptosis through the HIF‐1α–CX3CR1 axis.

Jing-Chun Pei, Bin Hu, Zhong-Hui Wen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.